| Catalog Number |
VBJR062502A |
| Medical Device Problem Code |
Device Contamination with Body Fluid (2317)
|
| Health Effect - Clinical Code |
Stenosis (2263)
|
| Date of Event |
12/09/2018
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Additional manufacturer narrative: review of the manufacturing records is pending.The device was not returned.Consequently, a direct product analysis was not possible.
|
| |
|
Event or Problem Description
|
|
The following was reported to gore by the implanting surgeon: the patient presented with stenosis in the sfa.A gore® viabahn® endoprosthesis was implanted (b)(6) 2018.The patient reported pain (b)(6) 2018 in the area of the implant.Computed tomography angiography (cta) on (b)(6) 2018 revealed the device was performing as expected.Another cta taken (b)(6) 2018 revealed fluid around the gore® viabahn® endoprosthesis.The device was explanted (b)(6) 2018.The doctor reported to gore the fluid around the device was cx positive from perivascular fluid staphylococcus lugdunensis (coagulase-negative, gram-positive bacterium that can be isolated as a component of normal skin flora in humans).
|
| |
|
Additional Manufacturer Narrative
|
|
Review of the manufacturing records indicated the lots met pre-release specifications.Additional information about this event could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional manufacturer narrative: refer to medwatch report #2017233-2018-00798 for other gore® viabahn® endoprosthesis involved with this event.
|
| |
|
Event or Problem Description
|
|
Additional information received indicates that two gore® viabahn® endoprosthesis were implanted (b)(6)2018 and explanted ((b)(6)2018) due to the reported infection.
|
| |
|
Search Alerts/Recalls
|